Advanced search×

Selective estrogen receptor modulator: the saga continues.

Steven R Goldstein

Menopause 17(2):231-2 (2010) PMID 20164814

DOI: 10.1097/gme.0b013e3181d12e65
Version: za2963e q8zae q8zb0 q8zc4 q8zd8 q8zec q8zf1 q8zg2

Similar articles you may find interesting…

  1. Determination of dopamine D2 receptor occupancy by lurasidone using positron emission tomography in healthy male subjects.
    Dean F Wong, Hiroto Kuwabara, and Antony Loebel

    Psychopharmacology (Berl) (2013) PMID 23649882

    In healthy volunteers, single doses of lurasidone 40-80 mg resulted in D2 receptor occupancy levels of >60 %, a level of receptor occupancy previously associated with clinical response for atypical antipsychotics....
  2. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
    Emma Yue Zhang, Massimo Cristofanilli, and William S Hancock

    J Proteome Res (2013) PMID 23647160

    We selected three breast cancer cell lines (SKBR3, SUM149 and SUM190) with different oncogene expression levels involved in ERBB2 and EGFR signaling pathways as a model system for the evaluation of selective integration of subsets of transcriptomic and proteomic data. We assessed the oncogene status...
  3. Selective binding of antimicrobial porphyrins to the heme-receptor IsdH-NEAT3 of staphylococcus aureus.
    Nhuan T Vu, Yoshitaka Moriwaki, and Kouhei Tsumoto

    Protein Sci (2013) PMID 23649633

    We recently reported that the extracellular heme receptor IsdH-NEAT3 captures and transfers non-iron antimicrobial porphyrins containing metals in oxidation state (III). However, it is unclear if geometric factors such as the size of the metal (ionic radius) affect binding and transfer of metallopor...